Mediclin AG buy kostojunior
Start price
05.06.16
/
50%
€5.40
Target price
05.12.16
€7.00
Performance (%)
5.89%
End price
05.12.16
€5.72
Summary
This prediction ended on 05.12.16 with a price of €5.72. With a performance of 5.89%, the BUY prediction by kostojunior for Mediclin AG closed with a slight gain. kostojunior has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Mediclin AG | -0.794% | -0.794% | -14.966% | -35.567% |
iShares Core DAX® | 2.147% | 2.681% | 17.410% | 16.694% |
iShares Nasdaq 100 | -0.578% | -0.816% | 24.107% | 34.957% |
iShares Nikkei 225® | 0.635% | 3.079% | 16.921% | 11.023% |
iShares S&P 500 | 0.746% | 0.171% | 23.802% | 37.315% |
According to kostojunior what are the pros and cons of Mediclin AG for the foreseeable future?
Pros
EBIT growth >5% per year expected
positive Cash Flow expected
Top 10 in its market
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Undervalued
Very high dividend yield expected
Small Risks for its business
Well known brand
Cons
Comments by kostojunior for this prediction
In the thread Mediclin AG diskutieren
Chart
start 5,55 LIMITE !!!!!!!!!
ziel höher.
----------------------------------------------------------
kj
(Laufzeit überschritten)
Stopped prediction by kostojunior for Mediclin AG
Mediclin AG
Start price
Target price
Perf. (%)
€3.32
13.11.22
13.11.22
€3.00
13.11.23
13.11.23
-0.60%
26.11.22
26.11.22
EBIT growth >5% per year expected
positive Cash Flow expected
Top 10 in its market
Future proof or reliable business model
Mediclin AG
Start price
Target price
Perf. (%)
€3.32
07.03.22
07.03.22
-
07.03.23
07.03.23
0.60%
19.03.22
19.03.22
EBIT growth >5% per year expected
positive Cash Flow expected
Top 10 in its market
Future proof or reliable business model
Mediclin AG
Start price
Target price
Perf. (%)
€4.36
10.01.21
10.01.21
€6.00
10.01.22
10.01.22
-15.14%
11.01.22
11.01.22
EBIT growth >5% per year expected
positive Cash Flow expected
Top 10 in its market
Future proof or reliable business model
Mediclin AG
Start price
Target price
Perf. (%)
€4.00
14.05.12
14.05.12
€4.90
14.11.12
14.11.12
-0.15%
14.11.12
14.11.12
EBIT growth >5% per year expected
positive Cash Flow expected
Top 10 in its market
Future proof or reliable business model
Mediclin AG
Start price
Target price
Perf. (%)
€3.98
23.11.10
23.11.10
€4.50
23.05.11
23.05.11
5.66%
23.05.11
23.05.11
EBIT growth >5% per year expected
positive Cash Flow expected
Top 10 in its market
Future proof or reliable business model
Mediclin AG
Start price
Target price
Perf. (%)
€3.10
03.03.10
03.03.10
€4.99
19.04.10
19.04.10
17.42%
19.04.10
19.04.10
EBIT growth >5% per year expected
positive Cash Flow expected
Top 10 in its market
Future proof or reliable business model